It is Safe to Co-Prescribe Nitrates and Erectile Dysfunction Meds, indicates real world data MD Bureau22 April 2022 9:00 AM ISTPresently, four PDE5 (phosphodiesterase type 5) inhibitors (sildenafil, vardenafil, tadalafil, and avanafil) are FDA approved in the US for the...
Women Experience Poor Health Outcome Pre & Post PCI compared to Men MD Bureau26 Feb 2022 9:00 AM ISTAcute myocardial infarction (AMI) is the most acute presentation of ischemic heart disease and the leading cause of mortality in men and women...
Hypertension complicating angina: Tackling the dual menace with amlodipine-atenolol combination dr. Abhimanyu Uppal27 Dec 2021 11:12 AM ISTEpidemiological studies have established a strong association between hypertension and coronary artery disease (CAD). (1) Hypertension is a major...
Holistic management of chest pain: Consensus Statement Medha Baranwal9 Oct 2021 9:30 AM ISTDelhi: A consensus statement, devised with the help of multiple meetings held across India, published in the JAPI: Journal of the Association of...
Women with PCOS at increased risk of cardiovascular events, study finds Medha Baranwal21 Sept 2021 11:30 AM ISTUK: A recent study has pointed that young women with polycystic ovary syndrome (PCOS) are at an increased risk of angina, heart attack, and...
Propranolol in cardiovascular diseases: The jack of all trades dr. Abhimanyu Uppal11 Aug 2021 12:57 PM ISTPropranolol is a competitive beta-adrenergic receptor antagonist that was developed by Sir James Black around six decades ago for the treatment of...
Reviewing the triple A in cardiology: The role of amlodipine-atenolol in angina relief dr. Abhimanyu Uppal27 July 2021 12:45 PM ISTAmlodipine, a charged dihydropyridine-type (DHP) calcium channel blocker (CCB), has been widely used to treat hypertension. (1) Amlodipine...
The versatile drug Trimetazidine: Applications in angina and beyond Dr Tiny Nair26 April 2021 12:45 PM ISTTrimetazidine (TMZ), an anti-anginal agent with a unique pleiotropic profile of actions on the cardiac cells making it an effective anti-anginal...
Trimetazidine in ATPCI Trial: Reading beyond the results Dr Tiny Nair21 Sept 2020 12:00 PM ISTOptimal management in post- Percutaneous Coronary Intervention (PCI) patients with medical therapy is one of the most important goals for any...
Trimetazidine fails to improve angina symptoms and outcomes after PCI: Lancet Dr. Kamal Kant Kohli31 Aug 2020 8:56 AM ISTTrimetazidine is an antianginal agent that improves energy metabolism of the ischaemic myocardium and might improve outcomes and symptoms of patients...
Stress induced brain activation may lead to Angina in CAD patients: Study Dr.Niharika Harsha B14 Aug 2020 2:00 PM ISTA recent study found that Inferior frontal lobe activation with mental stress is positively associated with angina at baseline and follow-up. The...
